Patent · US Active

Process for manufacturing 4-(2,2,3,3-tetrafluoropropyl)morpholine

US11760737B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

Adverio Pharma GmbH · DE

Inventors

Peter Fey · Wuppertal, DE
Sergii Pazenok · Solingen, DE
Christian Funke · Leichlingen, DE
Natalya Pavlovna Kolesnik · Horlivka, UA
Olexandr Ivanovich Guzyr · Horlivka, UA
Yuriy Grigorievich Shermolovich · Horlivka, UA

Key dates

Filing date	Jan 15, 2020
Grant date	Sep 19, 2023
Priority date	—
Expiry date	Aug 25, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D295/067
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present application relates to a novel, cost-saving and efficient process for preparing 4-(2,2,3,3-tetrafluoropropyl)morpholine which serves as an intermediate for production of medicaments and for production of medicaments for treatment and/or prophylaxis of cardiovascular disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.